Mirum Pharmaceuticals Inc. (MIRM)
Market Closed
17 Jul, 20:00
$
118. 86
+1.5
+1.2781%
$
7.45B Market Cap
- P/E Ratio
- Div Yield
435,900 Volume
-3.47 Eps
$ 117.36
Previous Close 
Want to track MIRM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mirum Pharmaceuticals Inc. (MIRM) Statistics
Valuation metrics
Market Cap 7.45B
Enterprise value 5.97B
Trailing P/E (ttm) -8.73
Forward P/E -176.74
PEG ratio 0
Price/Sales (ttm) 10.47
Price/Book (mrq) 28.85
Enterprise Value/Revenue 10.47
Enterprise Value/EBITDA -7.84
Overview
Shares outstanding 60.93M
Float 52.48M
Shares short 8.41M
% Held by insiders 0.01%
% Held by institutions 1.15%
Average volume (10 days) 555.88K
Average volume (90 days) 959K
Price summary
52-Week low 50.25
52-Week high 130
Beta 0.52
50-Day moving average 112.89
200-Day moving average 97.25
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.4%
Operating margin -0.12%
Operational effectiveness
Return on assets -0.9%
Return on equity -2.89%
Income Statement
Revenue (ttm) 569.61M
Revenue per share (ttm) 9.68
Quarterly revenue growth (yoy) 0.43%
Gross profit (ttm) 463.58M
EBITDA 17.21M
Net income to common (ttm) -798.84M
Diluted EPS (ttm) -13.57
Quarterly earnings growth (yoy) 0.43%
Balance Sheet
Total cash (mrq) 386.26M
Total cash per share (mrq) 6.56
Total debt (mrq) 323.78M
Total Debt/Equity (mrq) 1.34
Current ratio (mrq) 2.09%
Book value per share (mrq) 4.12
Cash Flow
Cash flow statement -170.98M
Levered free cash flow (LFCF) 166.9M
